Utama › Kanser Payudara › Illinois › Cicero
Kajian klinikal Kanser Payudara di Cicero, IL
11 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Cicero (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Mengambil pesertaFasa 3
- Hope And Healing Care, Hinsdale · 10 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi jauh
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi jauh
- dan 6 lagi
E-Mindfulness Approaches for Living After Breast Cancer
Mengambil pesertaFasa 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
- dan 1 lagi
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- Loyola University, Maywood · 5 mi jauh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- Loyola University Medical Center, Maywood · 5 mi jauh
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
- Elmhurst Memorial Hospital, Elmhurst · 10 mi jauh
- dan 1 lagi
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Mengambil pesertaFasa 1/2
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi jauh
- Advocate High Tech Medical Park, Palos Heights · 12 mi jauh
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Mengambil pesertaFasa 3
- Loyola University Medical Center, Maywood · 5 mi jauh
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- Affiliated Oncologists, Oak Lawn · 9 mi jauh
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Mengambil peserta
- Loyola University, Maywood · 5 mi jauh
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Cicero
- Kanser Paru-paru Bukan Sel Kecil24 kajian
- Kanser Paru-paru17 kajian
- Kanser Prostat14 kajian
- Kanser (semua jenis)13 kajian
- Leukemia Mieloid Akut11 kajian
- Kanser Kolorektal10 kajian
- Kanser Pundi Kencing8 kajian
- Melanoma7 kajian
- Penyakit Kardiovaskular7 kajian
- Kanser Metastatik7 kajian
- Mieloma Pelbagai6 kajian
- Limfoma Burkitt6 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.